Location: New York, NY
CIK: 0001633313 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value: $8.574B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP | 2,858,888 | $657M | 7.7% | $134.94 | +67.2% | Common | 91307C102 |
| APLS | APELLIS PHARMACEUTICALS INC | 11,111,111 | $653M | 7.6% | $48.71 | +30.9% | Common | 03753U106 |
| ASND | ASCENDIS PHARMA | 3,966,666 | $600M | 7.0% | $121.95 | — | Sponsored ADR | 04351P101 |
| SRPT | SAREPTA THERAPEUTICS INC | 4,344,444 | $562M | 6.6% | $106.42 | +15.1% | Common | 803607100 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,944,444 | $519M | 6.1% | $133.16 | +77.0% | Common | 558868105 |
| ARGX | ARGENX SE | 1,238,467 | $488M | 5.7% | $186.36 | — | Sponsored ADR | 04016X101 |
| KRYS | KRYSTAL BIOTECH INC | 2,555,555 | $455M | 5.3% | $77.73 | +78.7% | Common | 501147102 |
| XBI | SPDR SERIES TRUST - S&P BIOTECH | 4,300,000 | $408M | 4.8% | $89.29 | — | ETF | 78464A870 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 4,365,000 | $381M | 4.4% | $86.08 | +4.0% | Common | 09061G101 |
| FOLD | AMICUS THERAPEUTICS INC | 27,400,000 | $323M | 3.8% | $10.47 | +22.2% | Common | 03152W109 |
| — | CEREVEL THERAPEUTICS HLDNG | 7,555,555 | $319M | 3.7% | $39.80 | — | Common | 15678U128 |
| VKTX | VIKING THERAPEUTICS INC | 3,590,000 | $294M | 3.4% | $44.50 | 0.0% | Common | 92686J106 |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 8,555,555 | $245M | 2.9% | $31.70 | +0.9% | Common | 04280A100 |
| XENE | XENON PHARMACEUTICALS INC | 5,666,666 | $244M | 2.8% | $18.87 | +143.8% | Common | 98420N105 |
| — | ALPINE IMMUNE SCIENCES INC | 5,775,000 | $229M | 2.7% | $39.64 | — | Common | 02083G100 |
| VERA | VERA THERAPEUTICS INC | 5,265,000 | $227M | 2.6% | $35.64 | 0.0% | Common | 92337R101 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 11,700,000 | $173M | 2.0% | $14.36 | -19.0% | Common | 462260100 |
| — | INTRA-CELLULAR THERAPIES INC | 2,475,000 | $171M | 2.0% | $71.41 | — | Common | 46116X101 |
| KYMR | KYMERA THERAPEUTICS INC | 3,888,888 | $156M | 1.8% | $31.88 | +12.2% | Common | 501575104 |
| RNAM | AVIDITY BIOSCIENCES INC | 5,825,000 | $149M | 1.7% | $18.17 | -13.8% | Common | 05370A108 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 2,580,000 | $130M | 1.5% | $35.46 | +53.0% | CLASS A ORD | 61559X104 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 4,222,222 | $100M | 1.2% | $18.81 | +18.6% | Common | 87164F105 |
| MGNX | MACROGENICS INC | 6,150,000 | $90.53M | 1.1% | $15.11 | 0.0% | Common | 556099109 |
| KURA | KURA ONCOLOGY INC | 3,850,000 | $82.12M | 1.0% | $22.49 | -13.6% | Common | 50127T109 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 12,345,678 | $78.77M | 0.9% | $6.38 | — | Sponsored ADR | 05280R100 |
| SYRE | SPYRE THERAPEUTICS INC | 1,839,138 | $69.76M | 0.8% | $13.77 | +110.4% | Common | 00773J202 |
| SLNO | SOLENO THERAPEUTICS INC | 1,625,000 | $69.55M | 0.8% | $37.13 | +21.8% | Common | 834203309 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 13,050,000 | $66.29M | 0.8% | $10.72 | -47.5% | Common | 09058V103 |
| OCUL | OCULAR THERAPEUTIX INC | 7,148,936 | $65.06M | 0.8% | $7.10 | 0.0% | Common | 67576A100 |
| TSHA | TAYSHA GENE THERAPIES INC | 18,650,000 | $53.53M | 0.6% | $2.04 | +2.3% | Common | 877619106 |
| — | TOURMALINE BIO INC | 2,222,222 | $50.89M | 0.6% | $24.18 | — | Common | 89157D105 |
| ROIV | ROIVANT SCIENCES LTD | 4,651,162 | $49.02M | 0.6% | $8.94 | +20.6% | Common | G76279101 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 300,000 | $44.84M | 0.5% | $155.24 | +7.5% | Common | 02043Q107 |
| MNKD | MANNKIND CORP | 9,000,000 | $40.77M | 0.5% | $3.56 | +10.5% | Common | 56400P706 |
| — | MERUS N V | 888,888 | $40.03M | 0.5% | $25.54 | — | Common | N5749R100 |
| PCVX | VAXCYTE INC | 575,000 | $39.28M | 0.5% | $69.25 | 0.0% | Common | 92243G108 |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 830,000 | $38.75M | 0.5% | $49.13 | -4.0% | Common | 90400D108 |
| — | MARINUS PHARMACEUTICALS INC | 4,140,607 | $37.43M | 0.4% | $11.44 | — | Common | 56854Q200 |
| RCKT | ROCKET PHARMACEUTICALS INC | 1,260,900 | $33.97M | 0.4% | $18.18 | +56.3% | Common | 77313F106 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 4,535,000 | $31.97M | 0.4% | $17.04 | -65.2% | Common | 61225M102 |
| CGON | CG ONCOLOGY INC | 700,000 | $30.73M | 0.4% | $40.84 | 0.0% | Common | 156944100 |
| CRSP | CRISPR THERAPEUTICS AG | 419,580 | $28.6M | 0.3% | $71.59 | 0.0% | Common | H17182108 |
| — | VERRICA PHARMACEUTICALS INC | 3,999,999 | $23.68M | 0.3% | $6.66 | — | Common | 92511W108 |
| KYTX | KYVERNA THERAPEUTICS INC | 475,000 | $11.8M | 0.1% | $27.84 | 0.0% | Common | 501976104 |
| WHWK | AADI BIOSCIENCES INC | 2,849,402 | $6.668M | 0.1% | $24.27 | -92.1% | Common | 00032Q104 |
| — | ADVERUM BIOTECHNOLOGIES INC | 416,666 | $5.892M | 0.1% | $14.14 | — | Common | 00773U207 |